BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26506031)

  • 1. Use and Effectiveness of Gonadotropin-Releasing Hormone Agonists for Prophylactic Menstrual Suppression in Postmenarchal Women Who Undergo Hematopoietic Cell Transplantation.
    Poorvu PD; Barton SE; Duncan CN; London WB; Laufer MR; Lehmann LE; Marcus KJ
    J Pediatr Adolesc Gynecol; 2016 Jun; 29(3):265-8. PubMed ID: 26506031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of severe menorrhagia in oncology patients with treatment-induced thrombocytopenia by luteinizing hormone-releasing hormone agonist and depo-medroxyprogesterone acetate.
    Meirow D; Rabinovici J; Katz D; Or R; Shufaro Y; Ben-Yehuda D
    Cancer; 2006 Oct; 107(7):1634-41. PubMed ID: 16944540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The management of menstrual suppression and uterine bleeding: a survey of current practices in the Pediatric Blood and Marrow Transplant Consortium.
    Adegite EA; Goyal RK; Murray PJ; Marshal M; Sucato GS
    Pediatr Blood Cancer; 2012 Sep; 59(3):553-7. PubMed ID: 22331813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The use of GnRH agonists in severe uterine hemorrhages in adolescence caused by congenital aplastic and hypoplastic anemias].
    Nikolov A; Bŭrdarova I; Kolarov G; Veltova L
    Akush Ginekol (Sofiia); 1999; 38(2):46-8. PubMed ID: 10730389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GnRH agonists before surgery for uterine leiomyomas. A review.
    Crosignani PG; Vercellini P; Meschìa M; Oldani S; Bramante T
    J Reprod Med; 1996 Jun; 41(6):415-21. PubMed ID: 8799917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical study on the effectiveness and safety of combined laparoscopy and gonadotropin-releasing hormone agonist in the treatment of endometriosis].
    Song JH; Lu H; Zhang J; Li B
    Zhonghua Fu Chan Ke Za Zhi; 2013 Aug; 48(8):584-8. PubMed ID: 24199923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does medical debulking with gonadotrophin-releasing hormone agonist facilitate vaginal hysterectomy with a moderate enlarged uterus? A randomized control study.
    Elzaher MA; Moawad A; Madkour WA; Ali M; Salah Eldin Abdel Hamid AM; Zaheer H
    Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):326-30. PubMed ID: 23537617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Conservative surgery combined with depot medroxyprogesterone acetate in treatment of moderate or severe endometriosis].
    Zhou J; Lei ZW; Lü JQ; Sun J; Xu XW
    Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):5-8. PubMed ID: 15774083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral contraceptive therapy for polycystic ovary disease after chronic gonadotropin-releasing agonist administration. Predictors of continued ovarian suppression.
    Elkind-Hirsch KE; Anania C; Malinak R
    J Reprod Med; 1996 Sep; 41(9):645-52. PubMed ID: 8887188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resolution of Uterine Arteriovenous Malformation and Maintenance of Reproduction in 20 Women Treated with a GnRH Agonist Concomitantly with an Aromatase Inhibitor and Tranexamic Acid.
    Vilos AG; Oraif A; Machado M; Abu-Rafea B; Vilos GA
    J Obstet Gynaecol Can; 2019 Jun; 41(6):772-781. PubMed ID: 30413336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducing amenorrhea during bone marrow transplantation. A pilot study of leuprolide acetate.
    Laufer MR; Townsend NL; Parsons KE; Brody KA; Diller LR; Emans SJ; Guinan EC
    J Reprod Med; 1997 Sep; 42(9):537-41. PubMed ID: 9336747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral contraceptive pills, gonadotropin-releasing hormone agonists, or use in combination for treatment of hirsutism: a clinical research center study.
    Carr BR; Breslau NA; Givens C; Byrd W; Barnett-Hamm C; Marshburn PB
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1169-78. PubMed ID: 7714086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of endometrial thickness with the menstrual timing of leuprolide acetate administration for preoperative preparation for hysteroscopic surgery.
    Nathanson HG; Phillips DR; Milim SJ; Haselkorn JS; Kapra A
    J Am Assoc Gynecol Laparosc; 1997 Feb; 4(2):191-4. PubMed ID: 9050727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a gonadotropin-releasing hormone agonist to manage perimenopausal women with symptomatic uterine myomas.
    Wang PH; Lee WL; Cheng MH; Yen MS; Chao KC; Chao HT
    Taiwan J Obstet Gynecol; 2009 Jun; 48(2):133-7. PubMed ID: 19574174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Luteinizing hormone-releasing hormone analogue: leuprorelin acetate for the prevention of menstrual bleeding in premenopausal women undergoing stem cell transplantation.
    Chiusolo P; Salutari P; Sica S; Scirpa P; Laurenti L; Piccirillo N; Leone G
    Bone Marrow Transplant; 1998 Apr; 21(8):821-3. PubMed ID: 9603407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian function after hematopoietic cell transplantation: a descriptive study following the use of GnRH agonists for myeloablative conditioning and observation only for reduced-intensity conditioning.
    Phelan R; Mann E; Napurski C; DeFor TE; Petryk A; Miller WP; Wagner JE; Verneris MR; Smith AR
    Bone Marrow Transplant; 2016 Oct; 51(10):1369-1375. PubMed ID: 27272448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective treatment of severe menstrual migraine headaches with gonadotropin-releasing hormone agonist and "add-back" therapy.
    Murray SC; Muse KN
    Fertil Steril; 1997 Feb; 67(2):390-3. PubMed ID: 9022620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does preoperative treatment with a gonadotropin-releasing hormone agonist improve the outcome of endometrial resection?
    Vercellin P; Perin A; Consonn R; Oldan S; Parazzini F; Crosignani PG
    J Am Assoc Gynecol Laparosc; 1998 Nov; 5(4):357-60. PubMed ID: 9782138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the suppressive capacity of different depot gonadotropin-releasing hormone analogs in women.
    Filicori M; Flamigni C; Cognigni G; Dellai P; Arnone R; Falbo A; Capelli M
    J Clin Endocrinol Metab; 1993 Jul; 77(1):130-3. PubMed ID: 8325935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menstrual Suppression in Pediatric and Adolescent Patients with Disabilities Ranging from Developmental to Acquired Conditions: A Population Study in an Australian Quaternary Pediatric and Adolescent Gynecology Service from January 2005 to December 2015.
    Leeks R; Bartley C; O'Brien B; Bagchi T; Kimble RMN
    J Pediatr Adolesc Gynecol; 2019 Oct; 32(5):535-540. PubMed ID: 31181330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.